Bicycle Therapeutics (BCYC) Retained Earnings (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Retained Earnings data on file, last reported at $1.5 billion in Q2 2026.

• Quarterly Retained Earnings rose 2.27% year-over-year to $1.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.5 billion (up 2.27% YoY) and the FY2025 annual result came in at $1.5 billion, up 2.68% from the prior year.
• Retained Earnings steadied at $1.5 billion in Q2 2026, from $1.5 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $1.5 billion in Q2 2026 to a low of $578.3 million in Q1 2022.
• A 5-year average of $1.1 billion and a median of $1.2 billion in 2024 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2024 — Retained Earnings surged 129.28% — and 2026, when it advanced 2.27%.
• Tracing BCYC's Retained Earnings over 5 years: stood at $601.1 million in 2022, then jumped by 46.97% to $883.4 million in 2023, then soared by 66.72% to $1.5 billion in 2024, then rose by 2.68% to $1.5 billion in 2025, then advanced by 0.88% to $1.5 billion in 2026.
• The last three Retained Earnings figures came in at $1.5 billion (Q2 2026), $1.5 billion (Q1 2026), and $1.5 billion (Q4 2025), per Business Quant data.